Johnson & Johnson (JNJ.N): First quarter international sales were $10.73 billion, U.S. sales were $13.33 billion, global innovative drug sales were $15.43 billion, and global medical technology sales were $8.64 billion.
2026-04-14
Johnson & Johnson (JNJ.N): First quarter international sales were $10.73 billion, U.S. sales were $13.33 billion, global innovative drug sales were $15.43 billion, and global medical technology sales were $8.64 billion.